FDA Strategy for Complex Medical Devices
Done Right the First Time
A Different Kind of Regulatory Partner
Coladonato Consulting was built to support medical device companies facing complex, high stakes regulatory challenges where the path forward is not always clear and the margin for error is small.
We partner closely with our clients to bring structure, clarity, and confidence to every stage of the product lifecycle from early concept through FDA submission, commercialization, and every stage in between.
Class I, II & III
Devices
Spine, Orthopedics,
Combination Products
Strategy-First,
Execution-Driven
Our Approach
Strategy First
We identify the right regulatory pathway before work begins—reducing delays, rework, and FDA pushback.
Client Service
You get direct access, fast responses, and a partner who is fully invested in your success—not a layered consulting team.
Execution Under Pressure
Tight timelines, complex devices, unclear pathways—we operate effectively where others slow down.
Proven in High-Risk Devices
Deep experience in spine, orthopedic, and combination products where regulatory mistakes are costly.
Our Services
We align regulatory, clinical, quality, engineering, and biostatistics into one clear path to FDA success.
- Regulatory Strategy & Submissions
Define the right pathway upfront and execute with precision across 510(k), PMA, and De Novo. - Clinical Strategy & Study Execution
Design and manage clinical programs that directly support regulatory approval. - Quality & Compliance
Build scalable quality systems that support speed while meeting FDA and ISO requirements. - Engineering & Product Development
Ensure technical development, verification, and documentation align with regulatory goals. - Biostatistics
Turn complex data into clear, submission-ready evidence that withstands FDA scrutiny.
Who We Work With
We support small to mid-sized medical device companies that need:
- Clear direction in complex regulatory situations
- Senior-level expertise without building a large internal team
- A partner who can move quickly and deliver under pressure
Our Commitment
We measure success by our clients’ outcomes.
- Submissions that withstand FDA scrutiny
- Programs that stay on track under tight timelines
- Decisions grounded in sound regulatory and scientific rationale
A Clear, Efficient Path to FDA Success
- Strategy-first approach to reduce delays and rework.
- Deep expertise in Class II & III, spine, orthopedic, and combination products.
- Integrated support across regulatory, clinical, quality, engineering, and biostatistics.
- Direct access to senior experts with fast, responsive communication.
- Proven execution under tight timelines and high-stakes conditions.